RatnerPrestia Attorneys Participate in PBI’s 10th Annual I.P. Law Institute

Greater Philadelphia, PA | April 2016 – PBI’s 10th Annual I.P. Law Institute is scheduled for April 26-27, 2016 at the CLE Conference Center located at the Wanamaker Building in Philadelphia, PA. The course offers 12 PA CLE credits. It is targeted at attorneys who practice I.P. Law and PBI advertises that this year’s institute has something for everyone – from the novice to the expert.

Kenneth N. Nigon (Shareholder) and Andrew J. Koopman (Senior Associate) will present, “Patent Procurement and Strategy in the Era of Alice and Mayo” at the Tuesday afternoon session. The session will cover the PTO’s guidance over the last year regarding application of the subject matter eligibility requirement (35 U.S.C. § 101). Nigon and Koopman will discuss important subject matter eligibility examples published by the PTO, and will provide tips on responding to § 101 rejections during patent prosecution, as well as general tips concerning § 101.

Benjamin E. Leace (Shareholder) and Christopher H. Blaszkowski (Senior Associate) will present, “Indefiniteness at the PTO and in Court” at the Wednesday afternoon session. This track will examine the PTO’s guidance over the last year regarding application of the subject matter eligibility requirement (35 U.S.C. § 101).

For information about the event or to register, please click here.

RatnerPrestia is a law firm expert in all things IP. The Firm handles procurement, enforcement, licensing, commercialization, global strategic IP planning, and all related business aspects of IP. The Firm has attorneys experienced and successful in all relevant U.S. and German agencies and tribunals, including the U.S. Patent and Trademark Office, The German Patent Office, The European Patent Office, The U.S. International Trade Commission, and Federal Courts, both trial and appellate, in both the U.S. and Germany. With clients based around the world, RP understands that IP is global. For additional information, visit www.RatnerPrestia.com.